Centessa Pharmaceuticals plc
CNTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,756,521 | $1,913,029 | $2,211,838 |
| - Cash | $50,811 | $44,242 | $105,156 | $383,221 |
| + Debt | $117,575 | $118,141 | $117,996 | $117,226 |
| Enterprise Value | – | $1,830,420 | $1,925,869 | $1,945,843 |
| Revenue | $0 | $0 | $15,000 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $15,000 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | -$51,598 | -$46,455 | -$21,644 | -$107,570 |
| % Margin | – | – | -144.3% | – |
| Net Income | -$54,891 | -$50,343 | -$26,135 | -$111,329 |
| % Margin | – | – | -174.2% | – |
| EPS Diluted | -0.41 | -0.38 | -0.2 | -0.84 |
| % Growth | -7.9% | -90% | 76.2% | – |
| Operating Cash Flow | -$58,312 | -$22,452 | -$57,246 | -$42,800 |
| Capital Expenditures | -$234 | -$126 | $0 | $0 |
| Free Cash Flow | -$58,546 | -$22,578 | -$57,246 | -$42,800 |